Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
This is a 2-part, 2-arm, Phase 2 , multicentre, randomized, double-blind, placebo-controlled
study in adults with COVID-19 with gastrointestinal infection.